Predicting Fall Risk in Stroke Patients Using a Machine Learning Model and Multi-Sensor Data
NCT ID: NCT06380049
Last Updated: 2025-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
90 participants
OBSERVATIONAL
2024-05-20
2026-04-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validating Wireless Gait Sensor for Elderly Fall Risk Classification
NCT06398431
Development of Fall Prediction Model for Older Adults Based on Multi-faceted Data
NCT04723927
Assessing Fall Risk Using Transcranial Magnetic Stimulation and Quantitative Sensory Testing
NCT06480279
Development of Pressure Sensor Based Dementia and Fall Prevention Program for Older Adults
NCT06664229
THE EFFECTS OF A PROPRIOCEPTION-ENHANCING ASSISTIVE ORTHOSIS ON BALANCE AND JOINT SENSE IN GERIATRIC PATIENTS
NCT07017504
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study Design: This is a prospective, multicenter, open-label, confirmatory clinical trial. It involves collecting EMG data from stroke patients and applying machine learning techniques to predict fall risk. The study will compare the predictive accuracy of the machine learning model against conventional fall risk assessment tools.
Methods:
1. Participants:
• Sample Size: 80 stroke patients and 10 healthy adults to establish baseline EMG readings.
2. Interventions:
• Participants will undergo EMG signal collection from key lower limb muscles while performing standardized movements.
3. Outcome Measures:
* Primary Outcome: Sensitivity and specificity of the machine learning model in predicting high-risk fall patients.
* Secondary Outcomes: Comparison of the machine learning model's predictive performance with traditional fall risk assessment tools (e.g., Berg Balance Scale).
Data Collection:
* EMG sensors will be attached to the patients' muscles of the lower limbs. Sensors will record muscle activity during movement, which will then be analyzed using the machine learning model.
* The predictive model will be trained using features extracted from the EMG signals, and its performance will be validated against actual fall incidents reported during the follow-up period.
Statistical Analysis:
* The machine learning model's efficacy will be measured through its sensitivity (ability to correctly identify high-risk patients) and specificity (ability to correctly identify low-risk patients).
* Receiver Operating Characteristic (ROC) curves and Area Under the Curve (AUC) statistics will be used to assess model performance.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EMG Analysis Software
Surface electromyography devices are non-invasive tools that measure electrical activity produced by skeletal muscles through sensors placed on the skin.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* the onset of the stroke is less than 3months ago
* Lower extremity weakness due to stroke (MMT =\< 4 grade)
* Cognitive ability to follow commands
* 19 years and older
* Individuals who fully understand the necessity of the study and have voluntarily consented to participate as subjects
Exclusion Criteria
* other neurological abnormalities (e.g. parkinson's disease).
* severely impaired cognition
* serious and complex medical conditions(e.g. active cancer)
* cardiac pacemaker or other implanted electronic system
Health Participants
* other neurological abnormalities (e.g. parkinson's disease).
* severely impaired cognition
* serious and complex medical conditions(e.g. active cancer)
* cardiac pacemaker or other implanted electronic system
19 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Trade, Industry & Energy, Republic of Korea
OTHER_GOV
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Woo Hyung Lee, prof
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Hospital
Byung-Mo Oh, prof
Role: STUDY_DIRECTOR
Seoul National University Hospital
Han Gil Seo, prof
Role: STUDY_DIRECTOR
Seoul National University Hospital
Sung Eun Hyun, prof
Role: STUDY_DIRECTOR
Seoul National University Hospital
Hyunmi Oh, prof
Role: STUDY_DIRECTOR
National Traffic Injury Rehabilitation Hospital
Sumin Oh, B.S.
Role: STUDY_DIRECTOR
National Traffic Injury Rehabilitation Hospital
SO YEON JEON, B.S.
Role: STUDY_DIRECTOR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, Jongno, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
junghyun kim, Ph. D.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20240012366
Identifier Type: OTHER
Identifier Source: secondary_id
0720242110
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.